info@seagull-health.com
SeagullHealth
语言:
search

Who can use Quviviq(Daridorexant)?

Daridorexant (Quviviq) is an orexin receptor antagonist indicated for the treatment of adults with insomnia characterized by difficulty initiating and/or maintaining sleep.

Quviviq(Daridorexant)
Quviviq(Daridorexant)
Adult patients with difficulty initiating and/or maintaining sleep.
WeChat Scan
Free Inquiry
Related articles
Quviviq indications
Quviviq is a new generation of insomnia treatment drugs, and its unique pharmacological effects provide a new option for improving sleep disorders. This article will introduce the clinical applic...
Instructions for Quviviq: action and efficacy, dosage, side effects, precautions
Quviviq is a novel dual orexin receptor antagonist that was approved by the US FDA in 2022 for the treatment of insomnia in adults. This article will systematically introduce the core information...
共 2 条
  • 1
前往
New Drugs
Infigratinib(Truseltiq)
Infigratinib(Truseltiq)
Treatment of previously treated, unresectable locally advanced or metastatic...
Opicapone(Ongentys)
Opicapone(Ongentys)
Adjunctive treatment to levodopa/carbidopa for reducing "off" episodes in...
Deflazacort(Emflaza)
Deflazacort(Emflaza)
Treatment of Duchenne muscular dystrophy (DMD) in patients aged 2 years and...
Faricimab-svoa(Vabysmo)
Faricimab-svoa(Vabysmo)
Treatment of neovascular age-related macular degeneration, diabetic macular...
Counselling Service
Global Drug Search
Clinical Research Recruitment
Overseas Medical Treatment
Remote Consultations
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Submit
Business
  • Core products
  • Antitumor drugs
  • General drug
  • Antiviral drugs
  • Biological agents
Contact Us 
  • mailbox:info@lucius.la
Welcome to consult
ucius Pharmaceuticals (Lao) Co.,Ltd All rights reserved